Article Information
History
- October 9, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Tassawan Poomchaichote1,
- Niyada Kiatying-Angsulee2,
- Kanpong Boonthaworn1,
- Bhensri Naemiratch1,
- Supanat Ruangkajorn1,
- Ravikanya Praparsavath1,
- Chaiwat Thirapantu3,
- Karnjariya Sukrung3,
- Direk Limmathurotsakul1,4,5,
- Anne Osterrieder*,1,4 and
- Phaik Yeong Cheah1,4
- 1Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
- 2Drug System Monitoring and Development Centre, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
- 3Civicnet Foundation, Bangkok, Thailand
- 4Centre for Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
- 5Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
- ↵*Corresponding author: Anne Osterrieder (anne.osterrieder{at}ndm.ox.ac.uk)
Posted October 09, 2023.
Embedding community and public voices in co-created solutions to mitigate antimicrobial resistance (AMR) in Thailand using the ‘Responsive Dialogues’ public engagement framework
